SUBSTITUIERTE 4-HYDROXYPHENYLALKANSAURE-DERIVATE MIT AGONISTISCHER WIRKUNG AUF PPAR-GAMMA
A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | MOOK, ROBERT, ANTHONY, JR DEATON, DAVID, NORMAN DRIVE COLLINS, JON, LOREN HENKE, BRAD, RICHARD WILLSON, TIMOTHY, MARK COBB, JEFFREY, EDMOND SHARP, MATTHEW, JUDE KALDOR, ISTVAN ERICKSON, GREG, ALAN BOSWELL, GRADY, EVAN BRACKEEN, MARCUS O'CALLAGHAN, JOHN, MARK |
description | A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered hetrocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE205485TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE205485TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE205485TT13</originalsourceid><addsrcrecordid>eNqNjEsOgjAUANm4MOod6gGa-IHE7RMetAEKeX1VuyLE1JVRErx_7MIDuJrNzCwTb93ZsmankRhFKpUvqLv5XqHxDTQ1GAuOUBZI-gJRaTULqDqjY2ZzhSSummpnKgGuFH0PJCtoW1gni8f4nMPmx1WyLZFzJcP0HsI8jffwCp8hLg-7LD1lzPvjP84Xr2Ay4Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUIERTE 4-HYDROXYPHENYLALKANSAURE-DERIVATE MIT AGONISTISCHER WIRKUNG AUF PPAR-GAMMA</title><source>esp@cenet</source><creator>MOOK, ROBERT, ANTHONY, JR ; DEATON, DAVID, NORMAN ; DRIVE ; COLLINS, JON, LOREN ; HENKE, BRAD, RICHARD ; WILLSON, TIMOTHY, MARK ; COBB, JEFFREY, EDMOND ; SHARP, MATTHEW, JUDE ; KALDOR, ISTVAN ; ERICKSON, GREG, ALAN ; BOSWELL, GRADY, EVAN ; BRACKEEN, MARCUS ; O'CALLAGHAN, JOHN, MARK</creator><creatorcontrib>MOOK, ROBERT, ANTHONY, JR ; DEATON, DAVID, NORMAN ; DRIVE ; COLLINS, JON, LOREN ; HENKE, BRAD, RICHARD ; WILLSON, TIMOTHY, MARK ; COBB, JEFFREY, EDMOND ; SHARP, MATTHEW, JUDE ; KALDOR, ISTVAN ; ERICKSON, GREG, ALAN ; BOSWELL, GRADY, EVAN ; BRACKEEN, MARCUS ; O'CALLAGHAN, JOHN, MARK</creatorcontrib><description>A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered hetrocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5.</description><edition>7</edition><language>ger</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010915&DB=EPODOC&CC=AT&NR=E205485T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010915&DB=EPODOC&CC=AT&NR=E205485T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MOOK, ROBERT, ANTHONY, JR</creatorcontrib><creatorcontrib>DEATON, DAVID, NORMAN</creatorcontrib><creatorcontrib>DRIVE</creatorcontrib><creatorcontrib>COLLINS, JON, LOREN</creatorcontrib><creatorcontrib>HENKE, BRAD, RICHARD</creatorcontrib><creatorcontrib>WILLSON, TIMOTHY, MARK</creatorcontrib><creatorcontrib>COBB, JEFFREY, EDMOND</creatorcontrib><creatorcontrib>SHARP, MATTHEW, JUDE</creatorcontrib><creatorcontrib>KALDOR, ISTVAN</creatorcontrib><creatorcontrib>ERICKSON, GREG, ALAN</creatorcontrib><creatorcontrib>BOSWELL, GRADY, EVAN</creatorcontrib><creatorcontrib>BRACKEEN, MARCUS</creatorcontrib><creatorcontrib>O'CALLAGHAN, JOHN, MARK</creatorcontrib><title>SUBSTITUIERTE 4-HYDROXYPHENYLALKANSAURE-DERIVATE MIT AGONISTISCHER WIRKUNG AUF PPAR-GAMMA</title><description>A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered hetrocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEsOgjAUANm4MOod6gGa-IHE7RMetAEKeX1VuyLE1JVRErx_7MIDuJrNzCwTb93ZsmankRhFKpUvqLv5XqHxDTQ1GAuOUBZI-gJRaTULqDqjY2ZzhSSummpnKgGuFH0PJCtoW1gni8f4nMPmx1WyLZFzJcP0HsI8jffwCp8hLg-7LD1lzPvjP84Xr2Ay4Q</recordid><startdate>20010915</startdate><enddate>20010915</enddate><creator>MOOK, ROBERT, ANTHONY, JR</creator><creator>DEATON, DAVID, NORMAN</creator><creator>DRIVE</creator><creator>COLLINS, JON, LOREN</creator><creator>HENKE, BRAD, RICHARD</creator><creator>WILLSON, TIMOTHY, MARK</creator><creator>COBB, JEFFREY, EDMOND</creator><creator>SHARP, MATTHEW, JUDE</creator><creator>KALDOR, ISTVAN</creator><creator>ERICKSON, GREG, ALAN</creator><creator>BOSWELL, GRADY, EVAN</creator><creator>BRACKEEN, MARCUS</creator><creator>O'CALLAGHAN, JOHN, MARK</creator><scope>EVB</scope></search><sort><creationdate>20010915</creationdate><title>SUBSTITUIERTE 4-HYDROXYPHENYLALKANSAURE-DERIVATE MIT AGONISTISCHER WIRKUNG AUF PPAR-GAMMA</title><author>MOOK, ROBERT, ANTHONY, JR ; DEATON, DAVID, NORMAN ; DRIVE ; COLLINS, JON, LOREN ; HENKE, BRAD, RICHARD ; WILLSON, TIMOTHY, MARK ; COBB, JEFFREY, EDMOND ; SHARP, MATTHEW, JUDE ; KALDOR, ISTVAN ; ERICKSON, GREG, ALAN ; BOSWELL, GRADY, EVAN ; BRACKEEN, MARCUS ; O'CALLAGHAN, JOHN, MARK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE205485TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2001</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MOOK, ROBERT, ANTHONY, JR</creatorcontrib><creatorcontrib>DEATON, DAVID, NORMAN</creatorcontrib><creatorcontrib>DRIVE</creatorcontrib><creatorcontrib>COLLINS, JON, LOREN</creatorcontrib><creatorcontrib>HENKE, BRAD, RICHARD</creatorcontrib><creatorcontrib>WILLSON, TIMOTHY, MARK</creatorcontrib><creatorcontrib>COBB, JEFFREY, EDMOND</creatorcontrib><creatorcontrib>SHARP, MATTHEW, JUDE</creatorcontrib><creatorcontrib>KALDOR, ISTVAN</creatorcontrib><creatorcontrib>ERICKSON, GREG, ALAN</creatorcontrib><creatorcontrib>BOSWELL, GRADY, EVAN</creatorcontrib><creatorcontrib>BRACKEEN, MARCUS</creatorcontrib><creatorcontrib>O'CALLAGHAN, JOHN, MARK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MOOK, ROBERT, ANTHONY, JR</au><au>DEATON, DAVID, NORMAN</au><au>DRIVE</au><au>COLLINS, JON, LOREN</au><au>HENKE, BRAD, RICHARD</au><au>WILLSON, TIMOTHY, MARK</au><au>COBB, JEFFREY, EDMOND</au><au>SHARP, MATTHEW, JUDE</au><au>KALDOR, ISTVAN</au><au>ERICKSON, GREG, ALAN</au><au>BOSWELL, GRADY, EVAN</au><au>BRACKEEN, MARCUS</au><au>O'CALLAGHAN, JOHN, MARK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUIERTE 4-HYDROXYPHENYLALKANSAURE-DERIVATE MIT AGONISTISCHER WIRKUNG AUF PPAR-GAMMA</title><date>2001-09-15</date><risdate>2001</risdate><abstract>A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered hetrocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | ger |
recordid | cdi_epo_espacenet_ATE205485TT1 |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | SUBSTITUIERTE 4-HYDROXYPHENYLALKANSAURE-DERIVATE MIT AGONISTISCHER WIRKUNG AUF PPAR-GAMMA |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T02%3A54%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MOOK,%20ROBERT,%20ANTHONY,%20JR&rft.date=2001-09-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE205485TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |